Fundraising Fox
Breakout Labs
Venture capitalSeed–Series A
Find your way into Breakout Labs
Sign up to see every warm intro you have to Breakout Labs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Breakout Labs team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Breakout invests at the frontier where science and technology intersect, backing founders scaling scientific innovation across biotech, tech-bio, deep tech, hard tech, and chemistry-driven technology. With more than a decade of experience, its team of scientists and operators brings technical depth and commercial fluency to anticipate roadblocks and navigate complexity. Beyond capital, Breakout leverages a catalytic network of corporates, strategic partners, and next-stage investors to help portfolio companies gain traction, reach milestones faster, and scale into category-defining businesses.
Source: firm website, verified Aug 7, 2026.
What they invest in
from 13 of 14 portfolio companiesBiotech ×9Healthtech ×7Deep Tech ×5New Materials ×5AI & Machine Learning ×3Digital Health ×3Medical Devices ×3Advanced Manufacturing ×2
HQs:United States×8
Who they back
founder profiles across 6 portfolio companiesWhere their founders studiedfrom 10 founders with education data
Stanford University ×3Stanford University Graduate School of Business ×2UC San Diego ×2
What their founders studiedfrom 10 founders with field-of-study data
Engineering ×5Life Sciences ×3
Investments · 14 tracked
founders shown can be your intro pathBy year:2024 · 12020 · 12019 · 12016 · 14 dated
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ajay Shah(Founder)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)
BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in
Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout VenturesDolby Family VenturesEMV Capital+5 more
STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients.
BiotechDeep TechHealthtechLongevityMedical Devices
Michael Luther(CEO)in
Co-investorsAscension VenturesBreakout VenturesDelos CapitalNYBC VenturesBoehringer Ingelheim Venture FundKdT Ventures+1 more
Hyperion Biosystems builds diagnostic devices that use computer vision and physics-based algorithms to improve the sensitivity and specificity of point-of-care and at-home tests.
AI & Machine LearningHealthtechMedical Devices
Co-investorsNewlin Investment Company LLCSafar PartnersBoston Millennia PartnersCranberry CapitalPropel Venture PartnersThe Engine Ventures
Ecovative grows whole-cut meat alternatives and leather-like materials from mycelium using its AirMycelium indoor cultivation platform, which integrates with existing mushroom farming infrastructure.
BiotechFoodTechNew MaterialsGreen Island, US
Eben Bayer(Cofounder)inGavin McIntyre(Founder)in
BoardEvan Lodes(Director)Jerry Weinstein(Director)Charles Deull(Director)Jessica Harris(Director)
Co-investorsBreakout VenturesCool Climate CollectiveStray Dog CapitalTrousdale VenturesViking GlobalAiiM Partners+3 more
Epana Bio develops therapies for autoimmune diseases by leveraging genomics and AI to identify and target cellular origins of disease, with a focus on precision medicine for patient populations.
AI & Machine LearningBiotechDigital Health
Co-investorsBreakout VenturesHAWKTAILHummingbird VenturesOMX VenturesPoint Financial CapitalKdT Ventures+2 more
Glyscend Therapeutics is a clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and obesity.
BiotechDeep TechDigital HealthHealthtechLongevityBaltimore, US
Ashish Nimgaonkar(Executive Officer, Director)Dennis McWilliams(Director)inCasey Cunningham(Director)Leighton Read(Director)inBob Soh(Director)in
Co-investorsBrandon BioCatalystBrandon Capital Partners
Immusoft develops a cell therapy platform called Immune System Programming (ISP) that engineers a patient's B cells into plasma cells that produce therapeutic proteins after being infused back into the patient.
BiotechDeep TechHealthtechSeattle, US
Matthew Scholz(Founder)inSean Ainsworth(Chief Executive Officer)inRobert Sikorski(Chief Medical Officer)Rob Hayes(Chief Scientific Officer)inScott McIvor(Chief Development Officer)Eric Garcia(Executive Officer)in
Co-investorsBioRock VenturesBoston Harbor AngelsBreakout VenturesEQx FundInvariantes FundMichigan Capital Network+6 more
Maxterial develops advanced chemicals and coatings, including a coating platform designed to protect surfaces against wear, heat, and corrosion.
Advanced ManufacturingDeep TechNew Materials
Co-investorsAnthropocene VenturesDellin InvestmentsHelios Climate VenturesIdeashipUP2398
Modern Meadow develops animal-free, bio-fabricated leather alternatives using synthetic biology and material science for the fashion, interiors, and automotive industries.
BiotechCircular EconomyNew MaterialsPine Brook, US
Gabor Forgacs(Founder)inFrancoise Marga(Founder)inKaroly Jakab(Founder)inAnna Bakst(Executive Officer, Director)inRex Liu(Executive Officer)David Williamson(CEO)in
Co-investorsArtis VenturesAstanor VenturesBreakout VenturesCollaborative FundHorizons VenturesInventus Capital Partners+7 more
Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets.
AI & Machine LearningBiotechHealthtechSouth San Francisco, US
Jacob Rinaldi(Founder)inRonald Alfa(Executive Officer, Director, Promoter)Ron Alfa, MD, PhD(Co-Founder, CEO)inRon Alfa(Founder)Ron Alfa Jacob Rinaldi(Founder)
BoardJames Hardiman(Director)in
Co-investors11.2 CapitalBreakout VenturesCatalio Capital Management, LPEPIC VENTURESIntermountain HealthLinearis Ventures+6 more
Technology identifying supply chain sources using the environmental microbiome.
Co-investorsDolby Family VenturesGolden SeedsJ-VenturesWorking Capital FundAgFunderBlackhorn Ventures+4 more
Twelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology.
Advanced ManufacturingCleantechClimate TechHealthtechNew MaterialsMoses Lake, US
Nicholas Flanders(Founder)inEtosha Cave(Founder)inKendra Kuhl(Founder)inAndrew Cleeland(Executive Officer, Director)in
BoardMarc-Henri Galletti(Director)Nimesh Shah(Director)
Co-investorsBreakout VenturesDCVC (Data Collective)Dolby Family VenturesFifth WallAdvantage Partners Inc.Aera VC+36 more
ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields.
BiotechCircular EconomyClimate TechNew MaterialsSan Leandro, US
Harshal Chokhawala(Founder & CEO)inLindy Fishburne(Director)Phil Grayeski(Director)Taehong Huh(Director)Timothy Dummer(Executive Officer, Director)
Co-investorsAccelr8Breakout VenturesCavallo VenturesDudley FundFreshTracks CapitalPrime Partners+8 more
Portfolio news
latest coverage across their companiesImmusoft · immusoft.com · Mar 30, 2026
Frequently asked questions
- How many investments has Breakout Labs made?
- Breakout Labs has 14 tracked investments.
- What stage does Breakout Labs invest at?
- Breakout Labs invests at the Seed, Series A stages.
- What sectors does Breakout Labs focus on?
- Breakout Labs focuses on AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Hardware, Healthtech, New Materials.
- Does Breakout Labs lead rounds?
- Breakout Labs typically participates in rounds rather than leading them.
- Who does Breakout Labs co-invest with?
- Breakout Labs most often shares deals with Breakout Ventures, Dolby Family Ventures, Collaborative Fund, among 66 tracked co-investors.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Fly Ventures is an early-stage venture firm that backs founders at the zero-to-one stage, with portfolio companies going on to raise substantial follow-on funding from top US and European VCs.
Refactor is a seed-stage venture firm run as a solo capitalist by Zal, backing founders building hard tech companies that address real-world problems.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.